Literature DB >> 9104729

Vasculitis in systemic lupus erythematosus.

C Drenkard1, A R Villa, E Reyes, M Abello, D Alarcón-Segovia.   

Abstract

We studied the frequency, location, clinical and histopathological features, associated manifestations, and prognosis of vasculitides in a cohort of 667 SLE patients. Exclusion of patients with previous vasculitis or insufficient information left 540 patients, 194 of whom has vasculitis (incidence density: 0.053 new cases/person/year, cumulative incidence of 0.051 at one year, 0.232 at 5 years and 0.411 at 10 years). Vasculitis was confirmed by biopsy in 46 cases, by arteriography in five, and by both in three. A single episode of vasculitis occurred in 119 and two or more in 75 patients. Vasculitis was cutaneous in 160, visceral in 24, both in 10. In the first episode of cutaneous vasculitides, 111 had punctuate lesions, 32 palpable purpura, 6 urticaria, 6 ulcers, 8 papules, 5 erythematous plaques or macules confirmed with biopsy, 2 erythema with necrosis, and 1 panniculitis (plus small vessel vasculitis). Of 29 with visceral vasculitis in the first episode, 19 had mononeuritis multiplex, 5 digital necrosis, 3 large artery vasculitis of limbs, one mesenteric, and one coronary, more than one type could appear simultaneously or in subsequent episodes. Patients with vasculitis had longer disease duration and followup, younger age of onset of SLE, and were more frequently males than those without. Lupus manifestations associated with vasculitis in univariate logistic regression included myocarditis, psychosis, Raynaud's phenomenon, serositis, leukopenia, lymphopenia and pleuritis. Vasculitis also associated with the antiphospholipid syndrome. The strength of this association increased when patients with vasculitis confirmed by biopsy and/or arteriography were considered separately. Visceral vasculitis associated with increased mortality when controlled for age of onset and nephropathy.

Entities:  

Mesh:

Year:  1997        PMID: 9104729     DOI: 10.1177/096120339700600304

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  30 in total

Review 1.  Vasculitis in systemic lupus erythematosus.

Authors:  L Barile-Fabris; M F Hernández-Cabrera; J A Barragan-Garfias
Journal:  Curr Rheumatol Rep       Date:  2014       Impact factor: 4.592

2.  Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon.

Authors:  Samuel Katsuyuki Shinjo; Eloísa Bonfá
Journal:  Clin Rheumatol       Date:  2010-03-28       Impact factor: 2.980

3.  Anti-tubulin-α-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations.

Authors:  Xiaozhen Zhao; Yongjing Cheng; Yuzhou Gan; Rulin Jia; Lei Zhu; Xiaolin Sun
Journal:  Clin Rheumatol       Date:  2018-02-09       Impact factor: 2.980

Review 4.  Vasculitis associated with connective tissue disorders.

Authors:  Mittie K Doyle
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 5.  Microvascular involvement in systemic sclerosis and systemic lupus erythematosus.

Authors:  Didem Saygin; Kristin B Highland; Adriano R Tonelli
Journal:  Microcirculation       Date:  2019-04       Impact factor: 2.628

6.  Clinicopathological features of multiple mononeuropathy associated with systemic lupus erythematosus: a multicenter study.

Authors:  Elodie Rivière; Fleur Cohen Aubart; Thierry Maisonobe; François Maurier; Christophe Richez; Bruno Gombert; Marie Gousseff; Daniel Adoue; Alexis Mathian; Miguel Hié; Julien Haroche; Zahir Amoura
Journal:  J Neurol       Date:  2017-05-23       Impact factor: 4.849

7.  Dramatic development of severe SLE in a patient with an incomplete disease.

Authors:  G Fabio; M Carrabba; C Hu; M Floriani; C Besana
Journal:  Rheumatol Int       Date:  2005-01-21       Impact factor: 2.631

Review 8.  Lupus vasculitis: differential diagnosis with antiphospholipid syndrome.

Authors:  Theo Dov Golan
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 9.  Connective Tissue Disorder-Associated Vasculitis.

Authors:  Aman Sharma; Aadhaar Dhooria; Ashish Aggarwal; Manish Rathi; Vinod Chandran
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

10.  Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus and lupus nephritis.

Authors:  Hai-Feng Pan; Xue-Hui Fang; Guo-Cui Wu; Wen-Xian Li; Xue-Fei Zhao; Xiang-Pei Li; Jian-Hua Xu; Dong-Qing Ye
Journal:  Inflammation       Date:  2008-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.